Search
for

    Glossary Lenalidomide

    medication used to treat specific blood cancers by modulating immunity

    Lenalidomide is a medication primarily used to treat certain types of blood cancers, such as multiple myeloma and myelodysplastic syndromes. It works by modulating the immune system and inhibiting the growth of cancer cells. While it can be highly effective, it also has potential side effects, including an increased risk of blood clots and low blood cell counts.

    Research 9 of 92

    1. Hair repigmentation associated with the use of lenalidomide: Graying may not be an irreversible process! Journal of oncology pharmacy practice · 2012 · 25 citations
    2. Cutaneous adverse reactions linked to targeted anticancer therapies bortezomib and lenalidomide for multiple myeloma: new drugs, old side effects Cutaneous and Ocular Toxicology · 2013 · 18 citations
    3. Lenalidomide for refractory cutaneous manifestations of pediatric systemic lupus erythematosus Lupus · 2016 · 14 citations
    4. Lenalidomide Augments Differentiation of Cultured Hair Follicle Derived Melanocyte Stem Cells Into Functional Melanocytes Dermatology practical & conceptual · 2023
    5. Cutaneous Involvement in Systemic Lupus Erythematosus: A Review for the Rheumatologist The Journal of Rheumatology · 2022 · 11 citations
    6. Cyclophosphamide-associated acneiform drug eruption in a patient with multiple myeloma Journal of the American Academy of Dermatology · 2011 · 5 citations
    7. Recent Insight on the Management of Lupus Erythematosus Alopecia Clinical, Cosmetic and Investigational Dermatology · 2021 · 3 citations
    8. Tumor necrosis factor inhibitors and janus kinase inhibitors in the treatment of cicatricial alopecia: A systematic review PloS one · 2024
    9. Cutaneous Lupus Erythematosus Springer eBooks · 2017
    All research results →

    Learn

    — no results

    Try a deeper search in learn →

    Community

    — no results

    Try a deeper search in community →